Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display - Cocktail

1257 - Chemotherapy in Bulky Neck Mass DLBCL with Massive Gastrointestinal Bleeding Due to Erosive Gastritis and Myelodysplasia Syndrome : A Case Report

Date

24 Nov 2018

Session

Poster display - Cocktail

Topics

Tumour Site

Lymphomas

Presenters

Yasjudan Putra

Authors

Y.R. Putra, M.S. Hardianti

Author affiliations

  • Internal Medicine, Gadjah Mada University/Dr. Sardjito General Hospital, 55281 - Yogyakarta/ID
More

Resources

Abstract 1257

Case Summary

A 55-year-old Indonesian woman complained of bulky mass of the right neck. The patient also experienced massive upper gastrointestinal bleeding within last 2 months requiring a total 26 bags of PRC. Right neck mass size was 12 cm in diameter, hard in palpapation, and fixated. It deviated the trachea to the left side. Hematological profile showed the hemoglobin 8.2 mg/dL, leukocyte count 1.91 x103 /μL, platelet count 67 x103.The core biopsis of mass showed diffuse large B cell lymphoma (DLBCL). Bone marrow puncture showed Myelodysplastic Syndrome (MDS) with dyserythropoiesis and dysgranulopoiesis without lymphoma cell infiltration. Gastroscopy revealed gastropathy with multiple errosion in corpus and antrum. Because the mass endangered airway patency, we decided to perform chemotherapy despite the very high risk of rebleeding if trombosipenia deteriorated. During chemotherapy preparation, the patient experienced melena that needed 8 bags of packed red cell transfusion. We started CHOP regiment after transfusion with the baseline of blood count: Hb 11.3 g/dL, leukocyte count 2.42 x103/μL, platelet count 68 x103/μL. In order to minimize the cytopenic effect leading to reccurent bleeding, we reduced the dose of cyclophosphamide (50%) and doxorubicin (25%). One week after chemotherapy the right neck mass completely disappear, but the patient complained malaise and black tarry stool melena. A complete blood count revealed pancytopenia with hemoglobin 3,6 g/dL, leukocyte count 0,45 x103/μL,platelet count 34 x103/μL. We performed blood transfusion, filgrastim injection and lanzoprazol injection to manage the condition.
Conclusion: Chemotherapy in bulky neck mass of DLBCL which endangers airway patency concurrent with recurrent upper gastrointestinal tract bleeding and thrombocytopenia related MDS was a difficult choice. The decision to treat should be made based on the benefits outweigh the risk.

Editorial acknowledgement

Clinical trial identification

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.